Filing Details

Accession Number:
0001104659-17-037755
Form Type:
4
Zero Holdings:
No
Publication Time:
2017-06-06 20:28:42
Reporting Period:
2017-06-05
Filing Date:
2017-06-06
Accepted Time:
2017-06-06 20:28:42
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1660719 Aralez Pharmaceuticals Inc. ARLZ () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1258673 I Andrew Koven C/O Aralez Pharmaceuticals Inc.,
7100 West Credit Avenue, Suite 101
Mississauga A6 L5N 0E4
President & Chief Business Off No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Shares, Without Par Value Disposition 2017-06-05 161,906 $1.28 1,363,695 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. This represents shares sold by the issuer on behalf of the reporting person for payment of withholding tax liability incurred upon the vesting of 369,169 restricted stock units, which were previously granted on June 3, 2015 and which vested on June 3, 2017.
  2. This transaction was executed in multiple trades at prices ranging from $1.2700 to $1.2900. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.